COMMUNIQUÉS West-GlobeNewswire

T1D Exchange Teams with Tidepool to Leverage Device Data for Groundbreaking Study of Type 1 Diabetes
29/11/2018
Researchers to Focus on Daily, Mild to Moderate Fluctuations in Glucose Levels and the Impact on Patient Wellness BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced a research partnership with [...]
International Prix Galien Recognizes SPINRAZA® as Best Biotechnology Product
29/11/2018
Rare disease therapy honored with seven Prix Galien awards, including six independent country recognitions, for innovation in treating spinal muscular atrophy CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Biogen [...]
MacroGenics and Zai Lab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Margetuximab, MGD013 and TRIDENT™ Molecule in Greater China
29/11/2018
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing development Expand Zai Lab’s late-stage clinical pipeline with margetuximab and obtain rights to first-in-class [...]
The Real Impact of PAD - Pluristem Therapeutics to Host Key Opinion Leader Meeting on Peripheral Artery Disease
29/11/2018
HAIFA, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that [...]
Loop Industries Establishes Multi-Year Supply Framework with the Coca-Cola Cross Enterprise Procurement Group
29/11/2018
New Agreement Enables Authorized Coca-Cola Bottlers to Enter into Supply Agreements to Secure 100% Sustainable Loop™ Branded PET Plastic Resin MONTREAL, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: [...]
Transactions under Novozymes’ stock buyback program
29/11/2018
Novozymes has now completed the announced share buyback program of B shares worth up to DKK 2 billion in total during 2018. Please read the full announcement in the attached PDF Attachment 2018_66_Stock_Buybackprogram_EN
Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories
29/11/2018
BUFFALO, N.Y., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies
29/11/2018
Collaborations to provide Voyager the ability and flexibility to transfer its manufacturing expertise across multiple high-quality vendors to support the development of its pipeline programs CAMBRIDGE, Mass., Nov. 29, [...]
Akcea Announces Upcoming Data Presentations at the 2018 American Society of Hematology Annual Meeting
29/11/2018
Presentations focus on the benefits of treatment with TEGSEDI™ (inotersen) and results show continued efficacy with long-term exposure in the NEURO-TTR open-label extension study BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE [...]
ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
29/11/2018
Leading proxy advisory firm recognizes the strategic and financial merits of the merger BOSTON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on [...]
Antares Pharma Announces the Commercial Availability of XYOSTED™ (Testosterone Enanthate) Injection — A New Treatment for Adult Men Diagnosed With Testosterone Deficiency
29/11/2018
XYOSTED™ - A Novel Subcutaneous Testosterone Auto Injector Product Approved For Once-Weekly At-Home Therapy EWING, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the [...]
FDA Approves Firdapse® (amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS)
29/11/2018
- First evidenced-based medicine approved to treat LEMS - Catalyst Pathways™ designed to facilitate access to Firdapse® and provide dedicated patient support - Launch early in the first quarter of 2019 - Catalyst to [...]
US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US
29/11/2018
Invivoscribe also Receives National Reimbursement for CDx Assay in Japan SAN DIEGO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Invivoscribe is pleased to announce FDA approval of both the LeukoStrat CDx FLT3 Mutation Assay and [...]
Virginia Spine Institute Expands World-Class Surgical Team With Hiring of Spine Surgeon Ehsan Jazini, MD
29/11/2018
Spine Surgeon Ehsan Jazini, MD, formerly of MedStar Health, joins Virginia Spine Institute to support growth of national spinal practice RESTON, Va., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Virginia Spine Institute welcomes [...]
iKang Healthcare Group, Inc. Extends Shareholder Rights Plan
29/11/2018
BEIJING, Nov. 29, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), announced today that its board of directors (the “Board of Directors”) has unanimously approved the [...]
Chi-Med Enters into Multiple Collaborations to Evaluate Combinations of Surufatinib and Fruquintinib with PD-1 Checkpoint Inhibitors
29/11/2018
LONDON, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) entered into four collaboration agreements to evaluate the safety, tolerability and efficacy of Chi-Med’s [...]
LIDDS Delårsrapport juli - september 2018
29/11/2018
JULI - SEPTEMBER 2018 Nettoomsättningen uppgick till 7,8 (0,2) KSEK Kostnaderna uppgick till 2,5 (1,5) MSEK Resultatet före och efter skatt uppgick till 5,4 (-1,5) MSEK Resultat per aktie uppgick till 0,23 (-0,07) kr [...]
TRACON Pharmaceuticals and I-Mab Biopharma Announce Strategic Partnerships for Multiple Immuno-Oncology Programs
29/11/2018
I-Mab’s Broad and Innovative Pipeline to Leverage TRACON’s U.S. Product Development Solution Platform SAN DIEGO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical [...]
Rule 2.9 Announcement
29/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 29 November 2018 [...]

Pages